Cargando…
D37. Commercial Insurance Rates and Coding for Lymphedema Procedures: The Current State of Confusion and Need for Consensus
Autores principales: | Rochlin, Danielle H., Sheckter, Clifford C., Brazio, Philip S., Coriddi, Michelle, Dayan, Joseph, Mehrara, Babak J., Matros, Evan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125691/ http://dx.doi.org/10.1097/01.GOX.0000934760.88576.ed |
Ejemplares similares
-
D8. Lymphedema and Autoimmunity: Is There a Link?
por: Brown, Stav, et al.
Publicado: (2023) -
29. Natural History of Breast Cancer-related Lymphedema
por: Brown, Stav, et al.
Publicado: (2023) -
D18. Risk of Breast Cancer-Related Lymphedema: Development and Validation of a Clinically-Relevant, Patient-facing Prediction Model
por: Rochlin, Danielle H., et al.
Publicado: (2023) -
43. A Decade of Vascularized Lymph Node Transplant (VLNT) for the Treatment of Lymphedema: A Meta-analysis of Prospective Clinical Trials
por: Brown, Tal, et al.
Publicado: (2023) -
PC32. Non-invasive Detection of Subclinical Skin Changes in Lymphedema: A Promising Screening Method for Early Stage Disease
por: Brown, Stav, et al.
Publicado: (2023)